advanced search
Victoria Morgan
Director Strategic Marketing, Generics
West Pharmaceutical Services

Is this your profile?

About

Victoria Morgan is Director Strategic Marketing, Generics at West Pharmaceutical Services. Prior to that she was responsible for West’s global biologics
strategy development and implementation.

Ms Morgan brings a wealth of knowledge about scaling drug development through to and beyond commercialisation, predominantly in injectable drug delivery products including vials and combination products.

Throughout her tenures at West, Eli Lilly and Sanofi, Ms Morgan has served in various functions across sales and marketing, and she earned her Bachelor’s degree from the University of Wales, UK, and her MBA from INSEAD Business School in Paris, France.

Contributions

PREFILLED SYRINGES
RISING TO THE REGULATORY EVIDENCE CHALLENGE FOR HIGH-QUALITY COMBINATION PRODUCTS
Victoria Morgan and Stacy Gates-Rector explore how West is supporting pharma companies with packaging challenges through the supply of high-quality prefillable syringe plungers and provision of a highly co-ordinated technical documentation package.

More contributions

INDUSTRIALISATION
SUCCESSFUL INDUSTRIALISATION REQUIRES SOLID FOUNDATIONS
Jennifer Riter and Victoria Morgan discuss the importance of choosing the right containment system at the start for successful industrialisation of an injectable drug product.
INJECTION
BEING PREPARED FOR PHARMA INNOVATION IS KEY IN 2023
Victoria Morgan and Ana Marques Kuschel discuss three recent innovations that West Pharmaceutical Services has introduced to enable its partners to respond to specific market-driven challenges, from pandemic-driven pressures on fill-finish productivity to the underlying shift towards biologics and the accelerated growth of home-based treatment.
WEARABLES
THE EVOLUTION OF WEARABLES – REPRESENTING THE VOICE OF THE ENTIRE ECOSYSTEM
Lauren Orme, Victoria Morgan and Shari Krusniak consider the current landscape for on-body delivery systems and discuss how West Pharmaceutical Services is responding to the demands of various stakeholders.
WEARABLES
EASING PATIENT EXPERIENCE WITH INNOVATIVE LARGE-VOLUME WEARABLES
Victoria Morgan discusses the growing sector of wearable injectors, with a specific focus on West’s own SmartDose® injector and the value of fill-finish services.
WEARABLES
HOW LARGE-VOLUME WEARABLES REVOLUTIONISE THE PATIENT EXPERIENCE
Victoria Morgan looks at how the combination of large-volume medicines and the trend for wearable devices is transforming life for patients, highlighting the company's new-generation SmartDose 10 mL platform.
Figure 3: West’s on-body injector platform, SmartDose®.
WEARABLES
ALTERING PATIENT TREATMENT: HOW SC DELIVERY CAN HELP PATIENTS MANAGE CHRONIC CONDITIONS
Victoria Morgan looks at the benefits of combining an active pharmaceutical product with a novel subcutaneous delivery device, and highlights some of the partnerships West has with biopharmaceutical and other companies, which have led to market launches of products incorporating its on-body delivery system.
Top